T. Rowe Price Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $428M | Buy |
|
|||||
|
2025
Q1 | $370M | Sell |
|
|||||
|
2024
Q4 | $546M | Sell |
|
|||||
|
2024
Q3 | $1.14B | Buy |
|
|||||
|
2024
Q2 | $1.36B | Buy |
|
|||||
|
2024
Q1 | $1.1B | Buy |
|
|||||
|
2023
Q4 | $803M | Sell |
|
|||||
|
2023
Q3 | $749M | Buy |
|
|||||
|
2023
Q2 | $619M | Buy |
|
|||||
|
2023
Q1 | $602M | Buy |
|
|||||
|
2022
Q4 | $31.7M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $21.5M | Buy |
|